Press Review
-

Experts warn ADHD prescribing cascade and adult women diagnoses reframe masking – Press Review 10 January 2026
.
Key Takeaways Top story: Experts warn against ADHD prescribing cascades, urging systemic approaches over adding more medications. Diagnosis rates among adult women are increasing as long-masked symptoms gain recognition. AI task managers are emerging as “second brains” for neurodivergent professionals….
-

ADHD prescriptions surge for young adults and federal funding freezes hit neurodivergent childcare – Press Review 7 January 2026
.
Key Takeaways Top story: ADHD prescriptions for young adults and women rose 14% during the pandemic, highlighting increased reliance on medication. Federal funding freezes are threatening access to childcare for neurodivergent families, raising concerns about gaps in support systems. Fitness:…
-

Brain scans: ADHD stimulants mimic restful sleep and Homer1 gene may unlock new therapies – Press Review 30 December 2025
.
Key Takeaways Top story: Brain imaging finds ADHD stimulants replicate beneficial sleep patterns, challenging traditional focus-based views. Homer1 gene identified as a potential gateway for new, non-stimulant ADHD therapies. AI productivity tools are rapidly evolving to empower neurodivergent teams with…
-

CDC links adult ADHD to anxiety and mood disorders and one in nine children now diagnosed – Press Review 29 December 2025
.
Key Takeaways Top story: CDC data highlights strong connections between adult ADHD, anxiety, and mood disorders. A new EEG study suggests potential for objective ADHD measurement in children. One in nine U.S. children is now diagnosed with ADHD, according to…
-

New adult ADHD diagnostic standards proposed and diagnoses rise with workplace impact – Press Review 28 December 2025
.
Key Takeaways Top story: Major medical panel recommends updated adult ADHD diagnostic criteria to reduce misdiagnosis. ADHD diagnoses are rising nationwide, leading to evolving workplace accommodations. AI-powered note-taking tools are being developed for neurodivergent professionals to minimize cognitive overload. Companies…
-

Brain study rewrites ADHD stimulant action and mind wandering tied to creativity – Press Review 27 December 2025
.
Key Takeaways Top story: Scientists report that ADHD stimulant medications primarily enhance alertness, not directly focus, prompting a reassessment of their expected outcomes. New research links mind wandering in ADHD with greater creative problem-solving abilities, highlighting cognitive strengths within neurodivergence….
-

EEG study reveals brain patterns for ADHD and medication cascade risks in children – Press Review 26 December 2025
.
Key Takeaways Top story: New EEG study identifies measurable brain patterns for ADHD diagnosis. Report highlights concerns about medication cascade risks in children prescribed for ADHD. Stanford debate questions early medication practices for young children with ADHD. Viral video demonstrates…
-

Exercise added to ADHD care reduces adult symptoms and rising diagnoses shift school support – Press Review 25 December 2025
.
Key Takeaways Top story: Comprehensive analysis indicates that exercise enhances standard care, reducing adult ADHD symptoms. Brain imaging combined with genetics offers improved prediction of impulsivity in children with ADHD. The largest analysis confirms medication and cognitive behavioral therapy (CBT)…
-

ADHD children show brain patterns linked to treatment and UK study finds adult ADHD cuts life by 11 years – Press Review 23 December 2025
.
Key Takeaways Top story: Children with ADHD show unique brain activity, highlighting new possibilities for targeted therapies. One in four US adults suspect undiagnosed ADHD, but only a small fraction seek professional support. UK research links adult ADHD with an…
-

FDA clears LumosityRx as first ADHD brain training app and DEA proposes telehealth changes – Press Review 21 December 2025
.
Key Takeaways Top story: The FDA has cleared LumosityRx, making it the first prescription cognitive training app for adults with ADHD. The DEA has proposed changes to telehealth rules that could affect access to ADHD medication. Research indicates a gradual…
